Angiotensin receptor-binding molecule in leukocytes in association with the systemic and leukocyte inflammatory

Kotaro Haruhara1, Hiromichi Wakui2, Kengo Azushima3

  • 1Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan; Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.

Atherosclerosis
|February 7, 2018
PubMed

Insights

Leukocyte Angiotensin II type 1 receptor (AT1R)-associated protein (ATRAP) mRNA is abundant in healthy individuals and correlates with inflammation markers in non-communicable diseases (NCDs). ATRAP may act as an anti-inflammatory factor in NCDs.

Area of Science:

  • Immunology
  • Cardiovascular Science
  • Nephrology

Background:

  • The renin-angiotensin system in leukocytes contributes to non-communicable diseases (NCDs) like hypertension and atherosclerosis.
  • Angiotensin II type 1 receptor (AT1R)-associated protein (ATRAP) inhibits pathological AT1R signaling in animal models.
  • Investigating ATRAP expression and regulation in leukocytes is crucial for understanding NCDs.

Purpose of the Study:

  • To investigate the expression and regulation of ATRAP in human leukocytes.
  • To determine the association between leukocyte ATRAP mRNA levels and clinical variables in NCD patients.
  • To explore the role of ATRAP in leukocyte inflammation.

Main Methods:

  • Droplet digital polymerase chain reaction (ddPCR) was used to measure human leukocyte ATRAP mRNA.
  • Leukocyte ATRAP mRNA levels were analyzed in relation to clinical variables in 86 NCD outpatients.
  • Leukocyte cytokine mRNA was examined in bone-marrow ATRAP-deficient and wild-type chimeric mice after lipopolysaccharide injection.

Main Results:

  • ATRAP mRNA was highly expressed in leukocytes, particularly granulocytes and monocytes, of healthy subjects.
  • Leukocyte ATRAP mRNA levels positively correlated with granulocyte, monocyte counts, and C-reactive protein in NCD patients.
  • ATRAP mRNA levels were associated with inflammatory cytokines (IL-1β, TNF-α, MCP-1) in NCD patients' leukocytes. Leukocyte IL-1β was upregulated in ATRAP-deficient mice.

Conclusions:

  • Leukocyte ATRAP serves as a marker for systemic and leukocyte inflammation.
  • ATRAP appears to function as an anti-inflammatory factor in the pathophysiology of NCDs.
  • Further research into ATRAP's role could offer new therapeutic strategies for NCDs.
Abstract

Related Concept Videos

Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
2.0K
Classification of Leukocytes01:30

Classification of Leukocytes

Leukocytes are classified into two groups based on the presence or absence of cytoplasmic granules. Granular leukocytes, which contain granules, belong to the myeloid lineage and are divided into three subtypes: neutrophils, eosinophils, and basophils. These cells are roughly spherical and characterized by the granules in their cytoplasm.
Neutrophils are the most abundant type of granular leukocytes, comprising 50-70% of all leukocytes. They feature small, evenly distributed granules and a...
6.2K
Structure and Function of Leukocytes01:21

Structure and Function of Leukocytes

An adult in good health typically has between 4,500 and 11,000 leukocytes, or white blood cells, per microliter of blood, which constitutes about 1% of the total blood volume. Unlike red blood cells, white blood cells contain a nucleus and other cellular organelles but do not have hemoglobin. Most white blood cells reside in connective tissues, particularly in lymphatic organs such as the lymph nodes, with only a small fraction present in circulating blood.
White blood cells protect the body...
4.5K
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
2.8K
The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
15.3K
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
5.7K